Neuro-protective effects of Ligustri Fructus by suppression of oxidative stress in mouse model of Parkinson’s disease

被引:3
作者
Ye M. [1 ]
Kim M. [1 ]
Bae H. [1 ]
机构
[1] Department of Physiology, College of Korean Medicine, Kyung Hee University, #1, Hoegi-dong, Dongdaemungu, 130-701, Seoul
来源
Oriental Pharmacy and Experimental Medicine | 2016年 / 16卷 / 2期
基金
新加坡国家研究基金会;
关键词
Ligustri Fructus; MPTP; Parkinson’s disease; PC12; cell; ROS;
D O I
10.1007/s13596-016-0223-0
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a progressive degenerative disorder of the central nervous system (CNS) that leads to impairment of motor skills and speech. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes damage to the dopaminergic (DA) neurons, and 1-4-Methyl-4-phenylpyridinium (MPP+) causes cell death in differentiated PC12 cells that is similar to the degeneration that occurs in PD. Moreover, MPTP treatment increases the activity of the microglia cells that produced reactive oxygen species (ROS). We recently reported that Ligustri Fructus (LF), a widely used traditional herbal medicine, increases cell viability in a yeast model of PD. In the present study, we examined the inhibitory effect of LF (0.01, 5, 10 ug) on the neurotoxicity of MPTP in mice and on the MPP + -induced cell death in differentiated PC12 cells. In vivo experiment, MPTP injection revealed a significant loss of DA neurons in the substantia nigra, while LF (100, 200 mg/ kg) treatment dramatically reversed DA neuron loss in immunohistochemistry assay for tyrosine hydroxylase (TH). Furthermore, LF attenuated the MPP + -induced cell death, decreased the generation of ROS, and activated glutathione peroxidase in PC12 cells. These results suggest that LF may be beneficial for the treatment of neurodegenerative diseases such as PD. © 2016, Institute of Korean Medicine, Kyung Hee University and Springer Science+Business Media Dordrecht.
引用
收藏
页码:123 / 129
页数:6
相关论文
共 39 条
[1]  
Bao X., Wang Z., Fang J., Li X., Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis, Planta Med, 68, pp. 237-243, (2002)
[2]  
Beal M.F., Oxidatively modified proteins in aging and disease, Free Radic Biol Med, 32, pp. 797-803, (2002)
[3]  
Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F., Brain dopamine and the syndromes of Parkinson and Huntington. clinical, morphological and neurochemical correlations, J Neurol Sci, 20, pp. 415-455, (1973)
[4]  
Block M.L., Zecca L., Hong J.S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, pp. 57-69, (2007)
[5]  
Chiueh C.C., Krishna G., Tulsi P., Obata T., Lang K., Huang S.J., Murphy D.L., Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+, Free Radic Biol Med, 13, pp. 581-583, (1992)
[6]  
Choi D.K., Et al., Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice, J Neurosci, 25, pp. 6594-6600, (2005)
[7]  
Chung Y.C., Et al., Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation, Neuropharmacology, 60, pp. 963-974, (2011)
[8]  
Dauer W., Przedborski S., Parkinson’s disease: mechanisms and models, Neuron, 39, pp. 889-909, (2003)
[9]  
Dexter D.T., Jenner P., Parkinson disease: from pathology to molecular disease mechanisms, Free Radic Biol Med, 62, pp. 132-144, (2013)
[10]  
Fahn S., Cohen G., The oxidant stress hypothesis in Parkinson’s disease: evidence supporting it, Ann Neurol, 32, pp. 804-812, (1992)